COVID-19 patients display distinct SARS-CoV-2 specific T-cell responses according to disease severity
Authors:
- 1 February 2021
- journal article
- letter
- Published by Elsevier in Journal of Infection
- Vol. 82 (2) , 282-327
Abstract
No abstract availableKeywords
Funding Information
- Institut National de la Santé et de la Recherche Médicale
This publication has 9 references indexed in Scilit:
- Elevated nucleoprotein-induced interferon-γ release in COVID-19 patients detected in a SARS-CoV-2 enzyme-linked immunosorbent spot assayJournal of Infection, 2020
- Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, ChinaJournal of Infection, 2020
- Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed IndividualsCell, 2020
- Immunology of COVID-19: Current State of the ScienceImmunity, 2020
- Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort studyThe Lancet Infectious Diseases, 2020
- Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019Clinical Infectious Diseases, 2020
- Clinical and immunological features of severe and moderate coronavirus disease 2019Journal of Clinical Investigation, 2020
- Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in ChinaCell Host & Microbe, 2020
- Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological StudiesViruses, 2020